CClinicalTrials.gg
RecruitingNCT04675411Updated Aug 30, 2023

Smart Care for Older Persons Recovering From Hip-fracture Surgery

An interventional study of Smart care and usual care in Hip Fractures, sponsored by Chang Gung Memorial Hospital. Recruiting at 2 sites in Taiwan. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2023-08-30.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Registered 8 months after the study started (first participant enrolled Jan 2020, registered Sep 2020).
  • Started Jan 2020; still recruiting 6 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
158
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The proposed study aims to examine the costs and effects of a Smart Care Model using smart clothing with alarm sensors that detect fall risks and monitor/give feedback on continuously recorded daily activity levels.

This mixed-method study will include a quantitative component (a randomized control trial) and a qualitative component. Data will be collected and analyzed using an embedded type of mixed method, i.e., a small qualitative component will be embedded in a larger quantitative study. Before the study, we will seek institutional review board approval. The quantitative component, a randomized experimental design, will examine the effectiveness of the Smart Care Model. The control group will receive only usual care, and the experimental group will receive Smart Care. Subjects will be recruited from the trauma wards of Chang Gung Memorial Hospital (CGMH) at Linkou and New Taipei Tucheng hospital. The sample will include 158 subjects, with 79 in each group. Patients and caregivers in both groups will be assessed 8 times: at admission, before discharge, 1, 3, 6, 12, 18, and 24 months following hospital discharge. Outcomes will include (a) patient outcomes (clinical outcomes, self-care ability, adherence, service utilization, health-related quality of life [HRQoL] and cost of care), and (b) family caregiver outcomes (preparedness, perceived balance between competing needs, depressive symptoms and HRQoL). Analyses will follow an intention-to-treat principle. The effects of the Smart Care Model on health outcomes will be analyzed by hierarchical linear models. The qualitative component will follow the collection of quantitative data. A subset of 10 patients and their family caregivers will be chosen from participants who receive Smart Care, and 10 who receive routine care for in-depth personal interviews consisting of open-ended questions. Interviews will be transcribed verbatim and analyzed as suggested by Miles and Huberman (1994). After both quantitative and qualitative data are collected, the quantitative and qualitative results will be integrated, compared, and contrasted to fully explore the study aims.

Read the detailed description

Specific Aims and Hypothesis:

The proposed research aims to examine the effects of a Smart Care Model (SCM) on the health outcomes of older patients recovering from hip-fracture surgery (hip-fractured older patients) and on their caregivers' caregiving burden. The SCM entails real-time activity monitoring and feedback using smart clothing with sensors embedded in a computer network.

The proposed study has the following specific aims.

  1. To pretest, finalize and evaluate the protocol for the SCM.
  2. To evaluate the effectiveness of usual care and the SCM for hip-fractured elders in a randomized control trial. Effects of the two care models will be evaluated by comparing the trajectories of selected outcome variables: patients' clinical outcomes, self-care ability, subsequent falls, health-related quality of life (HRQoL), adherence, and service utilization as well as family caregivers' preparedness, perceived balance between competing needs, depressive symptoms, and HRQoL.

    During the first year after hospital discharge, hip-fractured elderly patients who receive the SCM will 2-1. Have better clinical outcomes, self-care ability, adherence and HRQoL and fewer subsequent falls than those who receive usual care.

    2-2. Have more outpatient visits and fewer hospital readmissions and emergency department visits than those who receive usual care.

    2-3. Family caregivers of hip-fractured patients receiving the SCM will have better preparedness, perceived balance between competing needs, and HRQoL as well as fewer depressive symptoms than caregivers of patients receiving usual care.

  3. If the effectiveness of the SCM is established, its cost-effectiveness will be analyzed from the perspectives of the health care system and society. The "incremental cost-effectiveness ratio" will be calculated to show the incremental costs for an additional quality-adjusted life year (QALY) of elderly hip-fractured patients receiving the SCM.
  4. To qualitatively explore the experiences of receiving the SCM for older hip-fractured persons and their family caregivers with in-depth interviews. The qualitative and quantitative components of the proposed study will be integrated to finalize the typical protocol, context and cases for implementing the SCM for older hip-fractured persons.

Basic Design:

Mixed methods,a concurrent embedded strategy in which quantitative and qualitative data are collected at the same time, with the quantitative component being predominant and the qualitative component collected from a sample subset , will be implemented. For the quantitative component, a randomized experimental design will be used to examine the effectiveness of the Smart Care Model (SCM) over a 5-year period. For the qualitative component, we will concurrently collect and compare qualitative data from a sample subset of patients and family caregivers who receive the SCM and those who receive usual care.Finally, the qualitative and quantitative data will be merged to provide comprehensive evidence and finalize protocols and typical cases for the SCM for hip-fractured older persons. The mixed-method approach has the advantages of confirming findings, validating and deepening understanding of the effects of care models, and broadening insights into the different issues underlying care models.

Intervention Models Participants in this trial will receive two care models: usual care and the Smart Care Model (SCM). The SCM will have two components: fall risk monitoring with an alarm, and activity-level monitoring with feedback. These SCM components are designed to enhance caregiver competence, decrease patient risk for subsequent falls, and improve postoperative recovery for hip-fractured patients with cognitive impairment. We have integrated the technology of remote monitoring with smart clothing into continuous rehabilitation and discharge planning, along with geriatric consultation. We will compare the effects of the SCM and usual care in this trial.

Participants Subjects will be recruited from the trauma wards of CGMH at Linkou and New Taipei Tucheng hospital.For the quantitative component, the sample size was estimated based on our interest in longitudinal changes in outcome variables. We plan to obtain at least 126 participants (63 for each group). Since fewer than 20% of cases were lost in our previous study, we estimated that 158 participants (79 in each group) would be adequate for the proposed study.

For the qualitative component, a subset sample of participants and family caregivers who received the SCM will be interviewed one-on-one to explore their experiences of receiving the SCM and compared with a subset of participants who received routine care. Ten patients and their family caregivers from the experimental group and 10 from the control group will be recruited.

Procedure As shown in Figure 5, potential subjects will be recruited by research assistants who will screen patient lists from the emergency department and hospital admissions twice a day to avoid losing potential cases. For patients who meet the study criteria, their primary physicians will be informed, and these potential subjects and their family caregivers will be invited to participate in this study. Elderly patients and their family caregivers who agree to participate will then be randomly assigned to the intervention or control group.

Randomization to groups will follow a randomization table created by our university statistician. The project manager will create sequentially numbered sealed envelopes containing group assignment. Each consenting patient and their family caregiver will receive the envelope in the order in which they are enrolled. The project manager will have access to the spreadsheet that indicates the randomization order, but not the research nurses who assess outcomes. After randomization, patients and their family caregivers in the experimental group will receive the SCM, and those in the control group will receive usual care. Patients and families will not be aware of their group enrollment and will be masked to the care model they receive. Research nurses who collect data will be independent of those who deliver the interventions. For the experimental group, the geriatric nurse will install sensors with the engineer during the home-environment assessment before hospital discharge and will spend around 60 minutes to help caregivers and patients use the smart clothing at home. Then a registered nurse will visit participants' homes once a week for 1 month after discharge, then once each month to help solve problems in using the smart-care system, download data, along with in-home rehabilitation. Each visit will take 30 to 60 minutes.

Patients and caregivers in both groups will be assessed 8 times longitudinally, each time around 30 minutes. The first assessment will be within 24 hours after hospital admission in the emergency department, and the second assessment will be in the wards after surgery and before discharge. The third, fourth, fifth, sixth, seventh and eighth assessments will be made 1, 3, 6, 12, 18 and 24 months after discharge, respectively. Families will keep weekly diaries to record rehabilitation and cost information. The incentive for diary recording will be enhanced by providing rewards. Qualitative data on experiences of using the SCM will be collected through 20-minute face-to-face interviews with a subset of at least 10 SCM-group and 10 routine-care patients and their family caregivers. They will be told that the interview questions have no right or wrong answers.

Data Analysis Quantitative Data Quantitative data will be analyzed under an intention-to-treat principle. This analysis will test three hypotheses about participants who receive the SCM vs. those who receive usual care. Hypothesis 2-1: elderly hip-fractured patients who receive the SCM will have better clinical outcomes, self-care ability, adherence and HRQoL and fewer subsequent falls; hypothesis 2-2: elderly hip-fractured patients who receive the SCM will have more outpatient visits and fewer hospital readmissions and emergency department visits; and hypothesis 2- 3: family caregivers of those who receive the SCM will have better preparedness, perceived balance between competing needs, and HRQoL, as well as fewer depressive symptoms than caregivers of those who receive usual care.

Changes in continuous outcome variables will be analyzed by hierarchical linear models (HLM), with usual care (control group) as the reference category. For binary outcome variables, a series of multilevel multinomial logit models will be estimated using usual care as the reference category. When we evaluate non-linear changes with time, the possibility of multicollinearity will be minimized by centering time at 3 and 6 months after discharge since the most rapid improvement in recovery occurs during the first 6 months. Finally, attrition will be accounted for by two dummy variables, one identifying subjects who died during the 1-year follow-up period, and the other identifying those who dropped out for other reasons. In addition, family caregiver characteristics (gender, age, education background and relationship with the hip-fractured person) will be compared between the experimental and control groups. Characteristics that differed significantly will be controlled in the HLM data analysis.

For specific aim 3, the "incremental cost-effectiveness ratio" will be calculated to demonstrate the incremental cost for an additional QALY of elderly hip-fractured patients receiving the SCM. Additionally, the robustness of the study results will be tested using multi-way sensitivity analysis.

Qualitative Data Transcripts and field notes will be coded line by line, with data collection and analysis concurrent. Data analysis will use three types of codes: descriptive, interpretative, and pattern. Descriptive codes imply little interpretation.Interpretive codes analyze or infer meaning from participants' words. Pattern codes are more inferential and explanatory. Data will be analyzed both within and across cases. Data analysis and collection will be discussed periodically among the research team. Memos will be written concurrently with data collection, coding and categorizing to record researchers' thoughts during data collection and analysis.

02

Conditions studied

  • Hip Fractures

Keywords

  • smart care
  • hip fractures
  • home nursing
  • family caregiver
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's planned enrollment of 158 is above the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ≥ 60 years old
  • admitted to CGMH from its emergency department due to one-side hip fracture,
  • received hip arthroplasty or internal fixation
  • can perform full range of motion against gravity and against some or full resistance
  • pre-fracture Chinese Barthel Index (CBI) score > 70
  • living in northern Taiwan (i.e., greater Taipei area, Keelung, Taoyuan, or Shin-Ju Province).

Exclusion criteria

Exclusion Criteria:

  • severe cognitive impairment that makes them unable to follow orders (Chinese Mini-Mental State Examination score \<10)
  • terminally ill
  • without a primary family caregiver
  • living in an institution.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
158 participants (estimated)

Study arms

  • Other
    usual care

    After a fall leading to hip fracture, patients are cared for by orthopedists and receive internal fixation or arthroplasty. Consultations for internal medicine care are occasionally made depending on the patient's condition. During the first 1 to 2 days after surgery, nurses teach patients how to exercise while still in bed, using caution while changing their position. Pain-relief medications and antibiotics are also administered (for 2-3 days). The first day after surgery, physical therapy usually starts with rehabilitation training only on patients receiving arthroplasty. The average hospital stay is 5 to 7 days. After hospital discharge, very few patients use in-home or community rehabilitation or are admitted to a 2-week subacute rehabilitation unit. Patients usually come back to the clinic around 1, 3, 6, and 12 months after hospital discharge. However, adherence to this follow-up schedule is poor. Telephone follow-ups are seldom used.

    Device: usual care

  • Experimental
    Smart Care Model

    The smart care model (SCM) will contain the components of geriatric assessment, continuous rehabilitation, and discharge planning. Sensors will be installed in bedrooms and living areas of the patient's home to receive signals from the smart clothing. Instant alerts and feedbacks from research nurses to family caregivers about the patient's condition and activity level will be provided.

    Device: Smart care

Interventions

  • DeviceSmart care

    Home based nursing intervention with smart assisted technology

    Also known as: usual care

  • Deviceusual care

    Routine hospital care with only in-hospital rehabilitation

06

What researchers measure

Primary outcomes

  1. muscle strength

    These outcomes will include muscle strength

    Time frame: from 1 to 24 months following hospital discharge

  2. muscle endurance

    These outcomes will include muscle endurance

    Time frame: from 1 to 24 months following hospital discharge

  3. flexibility

    These outcomes will include flexibility

    Time frame: from 1 to 24 months following hospital discharge

  4. complications

    These outcomes will include complications

    Time frame: from 1 to 24 months following hospital discharge

  5. mortality

    These outcomes will include mortality.

    Time frame: from 1 to 24 months following hospital discharge

  6. Range of motion

    These outcomes will include ROM of affected limb

    Time frame: from 1 to 24 months following hospital discharge

  7. pain intensity

    These outcomes will include pain

    Time frame: from 1 to 24 months following hospital discharge

  8. IADL

    Self-care abilities will include performance of IADL.

    Time frame: from 1 to 24 months following hospital discharge

  9. ADL

    Self-care abilities will include performance of ADLs.

    Time frame: from 1 to 24 months following hospital discharge

  10. length of hospital stay

    Information on service utilization will include length of hospital stay (LOS)

    Time frame: from 1 to 24 months following hospital discharge

  11. emergency department visits

    Information on service utilization will include emergency department visits

    Time frame: from 1 to 24 months following hospital discharge

  12. hospital re-admission rate

    Information on service utilization will include hospital re-admission rate

    Time frame: from 1 to 24 months following hospital discharge

  13. EQ5D

    HRQoL of hip-fractured older persons will be measured by the Taiwan-version five-dimension, three-level EuroQol questionnaire (EQ-5D-3L) for cost-effective analysis (Chang et al., 2007).

    Time frame: from 1to 24 months following hospital discharge

  14. Health-related quality of life (HRQoL)

    HRQoL of hip-fractured older persons will be measured by the SF-36 Taiwan-version (Lu, Tseng, \& Tsai, 2003; Shyu, Chen, Liang, Lu et al., 2004; Tseng, Lu, \& Tsai, 2003).

    Time frame: from 1to 24 months following hospital discharge

  15. Adherence

    We will measure the adherence to continuous rehabilitation. Family caregivers will be asked to keep a diary to record frequencies and types of daily rehabilitation performed by older persons as in our prior studies.

    Time frame: from 1 to 24 months following hospital discharge

  16. Cost of care

    Cost-effectiveness of the SCM will be analyzed from the perspectives of the health care system and society. All health care costs will be derived from actual hospital information-system costs, the National Health Insurance claims database, patient self-reported out-of-pocket payments, and data from published and unpublished sources.

    Time frame: from 1 to 24 following hospital discharge

Secondary outcomes

  1. Caregiver preparedness

    This outcome, defined as how ready caregivers believe they are for the tasks and stresses of caregiving, will be measured by the Preparedness Scale of the Family Caregiver Inventory (Archbold, Stewart, Greenlick, \& Harvath, 1990, 1992; Archbold, Stewart, Greenlick, \& Valanis, 1993; Huang et al., 2013)

    Time frame: 1, 3, 6, 12, 18, 24 months following hospital discharge

  2. Balance between competing needs

    Caregivers' perceived balance, or the degree to which they perceive they could simultaneously handle competing caregiving needs, will be assessed using the 18-item Chinese-version Finding a Balance Scale (Liu et al., 2014; Shyu, 2002).

    Time frame: 1, 3, 6, 12, 18, 24 months following hospital discharge

  3. Caregiver depressive symptoms

    Caregivers' depressive symptoms will be assessed using the 20-item, self-report Chinese-version Centre for Epidemiologic Studies Depression Scale (CES-D; Fu, Lee, \& Chen, 2003).

    Time frame: 1, 3, 6, 12, 18, 24 months following hospital discharge

  4. Caregiver HRQoL

    HRQoL of family caregivers will be measured by the SF-36 Taiwan-version (Lu, Tseng, \& Tsai, 2003; Shyu, Chen, Liang, Lu et al., 2004; Tseng, Lu, \& Tsai, 2003). HRQoL will also be measured by the Taiwan-version five-dimension, three-level EuroQol questionnaire (EQ-5D-3L) for cost-effective analysis (Chang et al., 2007).

    Time frame: 1, 3, 6, 12, 18, 24 months following hospital discharge

07

Study locations

2 of 2 sites recruiting
  • New Taipei Tucheng hospital
    New Taipei City, 236017, Taiwan
    • Yea-Ing L Shyu, PhD · Contact
    Recruiting
  • Chang Gung Memorial Hospital
    Taoyuan, Taiwan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04675411
Lead sponsor
Chang Gung Memorial Hospital
Collaborators
National Health Research Institutes, Taiwan, Chang Gung University
Responsible party
Yea-Ing Lotus Shyu (Professor, Chang Gung Memorial Hospital) — Principal investigator
First posted
Dec 19, 2020
Start date
Jan 1, 2020
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Aug 30, 2023

Study contacts

Yea-Ing L Shyu, PhD
Contact
yeaing@mail.cgu.edu.tw
032118800 ext. 5726

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion